Skip to Main Content

Third Rock Ventures is launching a new cancer diagnostics company called Thrive Sciences, according to a new corporation registration filed in Massachusetts last month.

The documents are vague about the new company’s specific targets. But the long list of directors listed on the form — many of whom have substantial expertise in liquid biopsy work — send a strong signal that Thrive will be working around that technology.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.